Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1035	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1041	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1090	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1119	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1212	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1213	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1457	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1561	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1713	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1745	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	1985	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	2093	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	2404	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	2600	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	2657	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	2661	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	2893	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	3554	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-	4471	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	16831	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	18258	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	18527	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	19567	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	20069	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	20284	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	21481	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	23117	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	24863	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	24993	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	25309	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	25504	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	25671	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	25740	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	25788	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	26717	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	27060	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	27295	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	27400	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	27522	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	27684	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	27692	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	28578	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	28976	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	29761	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	30098	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	30467	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	30990	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	31652	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	32361	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	32892	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	33269	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	33340	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	33385	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	33613	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	36579	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	36653	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	36746	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	38033	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	38881	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	38944	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	39233	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	39364	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	39616	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	39931	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	40564	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	40873	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	41124	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	42536	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	42597	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	42745	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	42770	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	43695	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	43733	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	43866	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	45480	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	45516	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	46361	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	47553	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	47668	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	48207	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	48578	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	48686	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	49090	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	49450	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	49493	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	49946	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	50416	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	50644	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	50776	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	51375	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	51867	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	52688	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	52771	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	53213	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	53324	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	54627	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	57992	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	58201	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	58890	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	59845	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	61958	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	65128	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	68579	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	71535	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	71844	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	73119	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	73830	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	74587	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	74684	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	78655	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	78933	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	98641	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	111198	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	122263	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+	131271	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	1985	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	6944	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	6959	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	6961	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	8106	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	8746	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	10901	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	11014	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	11031	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	11200	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	11580	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	11717	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	11906	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	12044	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	12502	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	12778	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	13018	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	13085	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	13201	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	13658	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	14590	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	14799	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	14804	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	15167	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	15753	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	16046	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	16140	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	16676	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	16721	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	16744	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	16751	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	17024	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	17183	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	17686	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	17984	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	18682	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	18790	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	BILIVERDIN (CAS# 114-25-0); (M+NA)+	19434	Peak area	Control	N	Exemestane	White	3 Month	N	N

Return to search page